Cloning of porcine neuron growth inhibitory factor (metallothionein III) cDNA and expression of the gene in Saccharomyces cerevisiae

Gene

Volumn 203, Issue 2, 1997, Pages 189-197

  Wang, Sue Hong ^a   Chang, Chung Yu ^a   Chen, Chien Fong ^a   Tam, Ming F ^b   Shih, Yang Hsin ^c   Lin, Lih Yuan ^a  

^a NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^b INSTITUTE OF MOLECULAR BIOLOGY   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Circular dichlorism; Metal binding affinity; Nucleotide sequence; Protein production; Sus scrofa; Yeast

Indexed keywords

BRAIN PROTEIN; BUFFER; COMPLEMENTARY DNA; GROWTH INHIBITOR; METAL; METAL ION; METALLOTHIONEIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; BINDING AFFINITY; BRAIN TOXICITY; CELL CULTURE; CELL GROWTH; CIRCULAR DICHROISM; CONTROLLED STUDY; CRANIAL NERVE; DNA LIBRARY; EXPRESSION VECTOR; GENE EXPRESSION; METAL BINDING; MOLECULAR CLONING; NONHUMAN; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN STABILITY; SACCHAROMYCES CEREVISIAE; YEAST CELL;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BRAIN CHEMISTRY; CADMIUM; CIRCULAR DICHROISM; CLONING, MOLECULAR; GROWTH INHIBITORS; HYDROGEN-ION CONCENTRATION; METALLOTHIONEIN; METALS; MOLECULAR SEQUENCE DATA; NERVE TISSUE PROTEINS; RECOMBINANT PROTEINS; RNA, MESSENGER; SACCHAROMYCES CEREVISIAE; SEQUENCE ANALYSIS, DNA; SPECTROPHOTOMETRY; SWINE; TRANSFORMATION, GENETIC;

EID: 0030784961     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1119(97)00513-1     Document Type: Article

References (33)

1. Ausubel, F.M., Brent, R., Kingston, R.E., Moore, D.D., Seidman, J.G., Smith, J.A., Struhl, K., 1989. In: Current Protocols in Molecular Biology. Preparation and analysis of RNA. Wiley, New York, pp. 4.8.1-4.9.5.
2. Chen C.-F., Wang S.-H., Lin L.-Y. Identification and characterization of metallothionein III (growth inhibitory factor) from porcine brain. Comp. Biochem. Physiol. 115B:1996;27-32.
3. Chernaik M.L., Huang P.C. Differential effect of cysteine-to-serine substitutions in metallothionein on cadmium resistance. Proc. Natl. Acad. Sci. USA. 88:1991;3024-3028.
4. Cismowski M.J., Huang P.C. Purification of mammalian metallothionein from recombinant systems. Meth. Enzymol. 205:1991;312-319.
5. 113Cd NMR. J. Biol. Chem. 266:1991;24390-24397.
6. Cousins R.J. Absorption, transport, and hepatic-metabolism of copper and zinc - Special reference to metallothionein and ceruloplasmin. Physiol. Rev. 65:1985;238-309.
7. Erickson J.C., Sewell A.K., Jensen L.T., Winge D.R., Palmiter R.D. Enhanced neurotrophic activity in Alzheimer's disease cortex is not associated with down-regulation of metallothionein-III (GIF). Brain Res. 649:1994;297-304.
8. Hamer D.H. Metallothionein. Annu. Rev. Biochem. 55:1986;913-951.
9. Hunziker P.E., Kaur P., Wan M., Kanzig A. Primary structure of seven metallothioneins from rabbit tissue. Biochem. J. 306:1995;265-270.
10. Ito H., Fukuda Y., Murata K., Kimura A. Transformation of intact yeast cells treated with alkali cations. J. Bacteriol. 153:1983;163-168.
11. Kagi, J.H.R., 1993. Evolution, structure and chemical activity of class I metallothionein: an overview. In: Suzuki, K.T., Kimura, M., Imura, N. (Eds.), Metallothionein III. Birkhaser, Basel, pp. 29-55.
12. Karin M. Metallothioneins: Proteins in search of function. Cell. 41:1985;9-10.
13. Kobayash H., Uchida Y., Ihara Y., Nakajima K., Kohsaka S., Miyatake T., Tsuji S. Molecular cloning of rat inhibitory factor cDNA and the expression in the central nervous system. Mol. Brain Res. 19:1993;188-194.
14. Koizumi S., Otaki N., Kimura M. Estimation of thionein systhesis in cultured cells by slab gel electrophoresis. Ind. Health. 20:1982;101-108.
15. Kozak M. Point mutation define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes. Cell. 44:1986;283-292.
16. Master B.A., Kelly E.J., Quaife C.J., Brinster R.L., Palmiter R.D. Targeted disruption of metallothionein I and II genes increases sensitivity to cadmium. Proc. Natl. Acad. Sci. USA. 91:1994;584-588.
17. Messerle B.A., Bos M., Schaffer A., Vasak M., Kagi J.H.R., Wuthrichrich K. Amide proton exchange in human metallothionein-2 measured by nuclear magnetic resonance spectroscopy. J. Mol. Biol. 214:1990;781-786.
18. Nielson K.B., Winge D.R. Preferential binding of copper to the β domain of metallothionein. J. Biol. Chem. 259:1984;4941-4946.
19. Onosaka S., Cherian M.G. The induced synthesis of metallothionein in various tissue of rats in response to metals. II. Influence of zinc status and specific effect on pancreatic metallothionein. Toxicology. 23:1982;11-20.
20. Palmiter R.D., Findley S.D., Whitmore T.E., Durnam D.M. MT-III, a brain-specific member of metallothionein gene family. Proc. Natl. Acad. Sci. USA. 89:1992;6333-6337.
21. Palmiter R.D. Constitutive expression of metallothionein-III (MT-III), but not MT-I, inhibits growth when cells become zinc deficient. Toxicol. Appl. Pharmacol. 135:1995;139-146.
22. Pountney D.L., Fundel S.M., Faller P., Birchler N.E., Hunziker P., Vasak M. Isolation, primary structures and metal binding properties of neuron growth inhibitory factor (GIF) from bovine and equine brain. FEBS Lett. 345:1994;193-197.
23. Quaife C.J., Findley S.D., Erickson J.C., Froelick G.J., Kelley E.J., Zambrowicz B.P., Palmiter R.D. Induction of a new metallothionein isoform (MT-IV) occurs during differentiation of stratified squamous epithelia. Biochemistry. 33:1994;7250-7259.
24. Robbins A.H., McRee D.E., Williamson M., Collett S.A., Xuong N.H., Furey W.F., Wang B.C., Stout C.D. Refined crystal structure of Cd, Zn metallothionein at 2.0 A resolution. J. Mol. Biol. 221:1991;1269-1293.
25. Sato M., Bremner I. Oxygen free radicals and metallothionein. Free Rad. Biol. Med. 14:1993;325-337.
26. Sewell A.K., Jensen L.T., Erickson J.C., Palmiter R.D., Winge D.R. Bioactivity of metallothionein-3 correlates with its novel β domain sequence rather than metal binding properties. Biochemistry. 34:1995;4740-4747.
27. Stennard F.A., Holloway A.F., Hamilton J., West A.K. Characterization of 6 additional human metallothionein genes. Biochim. Biophys. Acta. 1218:1994;357-365.
28. Stillman M., Cai W., Zelazowski A.J. Cadmium binding to metallothioneins. J. Biol. Chem. 262:1987;4538-4548.
29. Tsuji S., Kobayashi H., Uchida Y., Ihara Y., Miyatake T. Molecular cloning of human growth inhibitory factor cDNA and its down-regulation in Alzheimer's disease. EMBO J. 11:1992;4843-4850.
30. Uchida Y., Ihara Y., Tomonaga M. Alzheimer's disease brain exract stimulates the survival of cerebral cortical neurons from neonatal rats. Biochem. Biophys. Res. Commun. 150:1988;1263-1267.
31. Uchida Y., Tomonaga M. Neurotrophic action pf Alzheimer's disease brain extract is due to the loss of inhibitory factors for survival and neurite formation of cerebral cortical neurons. Brain. Res. 481:1989;190-193.
32. Uchida Y., Takio K., Titani K., Ihara Y., Tomonaga M. The growth inhibitory factor that is deficient in the Alzheimer's disease brain is 68 amino acid metallothionein-like protein. Neurology. 7:1991;337-347.
33. Uchida Y., Ihara Y. The N-terminal portion of growth inhibitory factor is sufficient for biology activity. J. Biol. Chem. 270:1995;3365-3369.